|
所在平台: Coursera |
课程主页: https://www.coursera.org/learn/opioid-mgmt
课程评论：没有评论
课程名称：高级执业提供者/医师助理：阿片类药物使用障碍药物辅助治疗豁免培训（24小时） 概述：该在线课程来自于弗吉尼亚大学医学院（UVASOM）与护理学院（SON）和美国成瘾精神病学学会（AAAP）的联合合作，并获得了数据2000的资助。课程旨在强调影响开处方临床医生的重要问题，涉及阿片类药物的新开处方和管理指南，适用于急性和慢性疼痛管理。本课程分为两个部分：第一部分包含8节独立课程，占24小时内容要求的一部分；第二部分包含其他16小时的内容，面向希望申请开处方丁丙诺啡以治疗阿片类药物使用障碍的高级执业提供者和医师助理。第一部分包括3个案例模块。第一和第二部分均包含评估模块后问题，需以80%的准确率完成。成功完成整个培训后将颁发结业证书。完成第一和第二部分将满足高级执业提供者和医师助理申请MAT豁免培训的24小时要求，以开处方丁丙诺啡治疗阿片类药物使用障碍。 完成该活动的预计时间：9.5小时 发布日期：2020年3月1日 UVA资助日期：2019年9月30日至2022年9月29日 该计划的资金由SAMHSA拨款提供。会议材料或出版物中的观点，以及发言人和主持人的观点，不一定反映卫生与公众服务部的官方政策；提及商业名称、商业实践或组织不表示得到美国政府的认可。 课程大纲： 第一部分 标题：APP/PA阿片类药物使用障碍MAT豁免培训第一部分 描述：该课程的总体目标是培训多样化的医疗专业人员，以安全和有效地开处方阿片类药物，以处理疼痛以及使用药物辅助治疗治疗物质使用障碍，特别是阿片类药物使用障碍。 第二部分 标题：APP/PA阿片类药物使用障碍MAT豁免培训第二部分 描述：提供最有效的药物治疗，以服务于各种环境中的患者，包括初级护理、精神病护理和疼痛管理设置。
Part: 1
Title:APP/PA Opioid Use Disorder MAT Waiver Part 1
Description:The overarching goal is to train a diverse range of healthcare professionals in the safe and effective prescribing of opioid medications for the treatment of pain, as well as the treatment of substance use disorders, particularly opioid use disorders, with medication-assisted treatments.
Part: 2
Title:APP/PA Opioid Use Disorder MAT Waiver Training Part 2
Description:To make available the most effective medication treatments to serve patients in a variety of settings, including primary care, psychiatric care, and pain management settings.
This online course opportunity is made possible through a joint partnership with University of Virginia School of Medicine (UVASOM) and Nursing (SON) and the American Academy of Addiction Psychiatry (AAAP), Data 2000 sponsor for this MAT waiver training. This content was created by the AAAP and has been used with permission. This course is designed to highlight important issues affecting prescribing clinicians regarding the new requirements and guidelines in opioid prescribing and management for acute and chronic pain management. This course is divided into two parts; part 1 consists of 8 individual sessions of the required 24 hours of content; part 2 consists of the remaining 16 hours of content for advanced practice providers and physician assistants who wish to apply for a waiver to prescribe buprenorphine for the treatment of opioid use disorders. There are 3 case modules in part 1. Both part 1 & 2 contain graded post-module questions, the total of which must be completed with 80% accuracy. A certification of completion will be issued for successful completion of the entire training. Successful completion of both parts 1 and part 2 will satisfy the 24 hour requirement for MAT waiver training for advanced practice providers and physician assistants to prescribe buprenorphine for the treatment of opioid use disorders. Estimated time to complete this activity: 9.5 hours Release date: March 1, 2020 UVA Grant Dates: 09/30/2019 – 09/29/2022 Funding for this initiative was made possible by a grant from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
